Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steve T Yeh

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 23, 2015
Suppressing angiotensinogen synthesis attenuates kidney cyst formation in a Pkd1 mouse modelTakamitsu Saigusa, Yujing Dang, Adam E Mullick, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 23, 2018
Whole-Body but Not Hepatic Knockdown of Chemerin by Antisense Oligonucleotide Decreases Blood Pressure in RatsDavid J Ferland, Bridget Seitz, Emma S Darios, et al.
Nucleic Acid Therapeutics|May 25, 2022
Targeted Delivery of Antisense Oligonucleotides Through Angiotensin Type 1 ReceptorCarol Kuo, Mehran Nikan, Steve T Yeh, et al.
Physiological Genomics|October 8, 2019
Different blood pressure responses in hypertensive rats following chemerin mRNA inhibition in dietary high fat compared to dietary high-salt conditionsDavid J Ferland, Emma D Flood, Hannah Garver, et al.
Nucleic Acids Research|May 26, 2019
Fatty acid conjugation enhances potency of antisense oligonucleotides in muscleThazha P Prakash, Adam E Mullick, Richard G Lee, et al.
Pathogens (Basel, Switzerland)|May 28, 2022
Virus-Derived Chemokine Modulating Protein Pre-Treatment Blocks Chemokine-Glycosaminoglycan Interactions and Significantly Reduces Transplant Immune DamageIsabela R Zanetti, Michelle Burgin, Liqiang Zhang, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|November 30, 2013
Reduction of early reperfusion injury with the mitochondria-targeting peptide bendaviaDavid A Brown, Sharon L Hale, Christopher P Baines, et al.
International Journal of Molecular Sciences|March 10, 2022
Antisense Therapy Attenuates Phospholamban p.(Arg14del) Cardiomyopathy in Mice and Reverses Protein AggregationTim R Eijgenraam, Nienke M Stege, Vivian Oliveira Nunes Teixeira, et al.
The Journal of Clinical Investigation|July 27, 2018
Endothelial cell CD36 optimizes tissue fatty acid uptakeNi-Huiping Son, Debapriya Basu, Dmitri Samovski, et al.
Nature Communications|August 31, 2021
Phospholamban antisense oligonucleotides improve cardiac function in murine cardiomyopathyNiels Grote Beverborg, Daniela Später, Ralph Knöll, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 23, 2015
Suppressing angiotensinogen synthesis attenuates kidney cyst formation in a Pkd1 mouse modelTakamitsu Saigusa, Yujing Dang, Adam E Mullick, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 23, 2018
Whole-Body but Not Hepatic Knockdown of Chemerin by Antisense Oligonucleotide Decreases Blood Pressure in RatsDavid J Ferland, Bridget Seitz, Emma S Darios, et al.
Nucleic Acid Therapeutics|May 25, 2022
Targeted Delivery of Antisense Oligonucleotides Through Angiotensin Type 1 ReceptorCarol Kuo, Mehran Nikan, Steve T Yeh, et al.
Physiological Genomics|October 8, 2019
Different blood pressure responses in hypertensive rats following chemerin mRNA inhibition in dietary high fat compared to dietary high-salt conditionsDavid J Ferland, Emma D Flood, Hannah Garver, et al.
Nucleic Acids Research|May 26, 2019
Fatty acid conjugation enhances potency of antisense oligonucleotides in muscleThazha P Prakash, Adam E Mullick, Richard G Lee, et al.
Pathogens (Basel, Switzerland)|May 28, 2022
Virus-Derived Chemokine Modulating Protein Pre-Treatment Blocks Chemokine-Glycosaminoglycan Interactions and Significantly Reduces Transplant Immune DamageIsabela R Zanetti, Michelle Burgin, Liqiang Zhang, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|November 30, 2013
Reduction of early reperfusion injury with the mitochondria-targeting peptide bendaviaDavid A Brown, Sharon L Hale, Christopher P Baines, et al.
International Journal of Molecular Sciences|March 10, 2022
Antisense Therapy Attenuates Phospholamban p.(Arg14del) Cardiomyopathy in Mice and Reverses Protein AggregationTim R Eijgenraam, Nienke M Stege, Vivian Oliveira Nunes Teixeira, et al.
The Journal of Clinical Investigation|July 27, 2018
Endothelial cell CD36 optimizes tissue fatty acid uptakeNi-Huiping Son, Debapriya Basu, Dmitri Samovski, et al.
Nature Communications|August 31, 2021
Phospholamban antisense oligonucleotides improve cardiac function in murine cardiomyopathyNiels Grote Beverborg, Daniela Später, Ralph Knöll, et al.
Pageof 2